No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs12453682 |
chr17:37770005-37770006 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs558887587 |
chr17:37770006-37770007 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs574650603 |
chr17:37770011-37770012 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs577161660 |
chr17:37770023-37770024 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs574643041 |
chr17:37770094-37770095 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs12946926 |
chr17:37770102-37770103 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs78256851 |
chr17:37770134-37770135 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs553298265 |
chr17:37770156-37770157 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs540139066 |
chr17:37770157-37770158 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs138550004 |
chr17:37770216-37770217 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs78713857 |
chr17:37770226-37770227 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs186932105 |
chr17:37770227-37770228 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs530998373 |
chr17:37770270-37770271 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs191741131 |
chr17:37770287-37770288 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs184790025 |
chr17:37770292-37770293 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs184329828 |
chr17:37770299-37770300 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs144049636 |
chr17:37770309-37770310 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs72343132 |
chr17:37770329-37770330 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs200739504 |
chr17:37770330-37770331 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs60658256 |
chr17:37770341-37770342 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs565648516 |
chr17:37770347-37770348 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs55942935 |
chr17:37770356-37770357 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
23 |
rs548297934 |
chr17:37770365-37770366 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs569911645 |
chr17:37770376-37770377 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs537244620 |
chr17:37770385-37770386 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs545958519 |
chr17:37770411-37770412 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs139210213 |
chr17:37770422-37770423 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs534887237 |
chr17:37770428-37770429 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs9915323 |
chr17:37770481-37770482 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
30 |
rs574757670 |
chr17:37770485-37770486 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs188875421 |
chr17:37770555-37770556 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs149280289 |
chr17:37770572-37770573 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs193160804 |
chr17:37770578-37770579 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs555278696 |
chr17:37770591-37770592 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs564311769 |
chr17:37770618-37770619 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs528814706 |
chr17:37770624-37770625 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs75349857 |
chr17:37770669-37770670 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs74451218 |
chr17:37770687-37770688 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs529692099 |
chr17:37770716-37770717 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs144483570 |
chr17:37770839-37770840 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs563378713 |
chr17:37770860-37770861 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs79761132 |
chr17:37770878-37770879 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs185419770 |
chr17:37770900-37770901 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs377525345 |
chr17:37770914-37770915 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs534644586 |
chr17:37770930-37770931 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs9891817 |
chr17:37770987-37770988 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs568408551 |
chr17:37770995-37770996 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs535467611 |
chr17:37771007-37771008 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs556903190 |
chr17:37771034-37771035 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs113488714 |
chr17:37771038-37771039 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|